a4cell

Lab-in-a-cell-devices

General Information
Company Name
a4cell
Founded Year
2018
Location (Offices)
Spain +2
Founders / Decision Makers
Number of Employees
17
Industries
Biotechnology, Life Sciences
Funding Stage
Series Unknown
Social Media

a4cell - Company Profile

ARRAYS-FOR-CELL NANODEVICES

Slogan: Lab-in-a-cell-devices

Description: Arrays-for-Cell Nanodevices offers a dynamic film about cell sensing through its SPAchip® technology. This innovative technology is based on intracellular silicon microchips printed with multiple fluorescent probes, enabling the analysis and monitoring of cellular pathways in real-time intracellular processes.

The cell-based assays based on SPAchip® are compatible with High Content Screening platforms and imaging analyzers, positioning the company at the forefront of biotechnological advancements.

Founded: 2018

Industries: Biotechnology

Headquarter: Spain

Last Investment: €3.00M Venture Round investment at 19 October 2023

Last Investment Investors: BeAble Capital, Dreavent Capital, INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA

The latest €3.00M Venture Round investment in ARRAYS-FOR-CELL NANODEVICES, received from notable investors including BeAble Capital, Dreavent Capital, and INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA, showcases the growing interest in the company's innovative technologies. The company's unique approach to intracellular analysis through SPAchip® technology positions it as a leading player in the biotechnology industry. Their compatibility with High Content Screening platforms and imaging analyzers signifies significant potential for growth and impact in the field. With its headquarters in Spain, the company's emphasis on real-time intracellular processes sets it on a promising trajectory within the biotechnology sector.

Taxonomy: Cell Analysis, Microfluidics, High Content Screening, Intracellular Technology, Fluorescent Probes, Cellular Pathways, Real-time Monitoring, Intracellular Imaging, Assay Technology, Cellular Microchips

Funding Rounds & Investors of a4cell (5)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round €3.00M 3 Dreavent Capital, INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA 19 Oct 2023
Venture Round €1.25M 2 21 Dec 2021
Series A €556.27K 2 INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA 16 Dec 2020
Seed Round €345.03K 1 15 Jul 2019
Pre Seed Round €157.85K 1 06 Feb 2018

Latest News of a4cell

View All

No recent news or press coverage available for a4cell.

Similar Companies to a4cell

View All
Flow Contract Site Laboratory, LLC - Similar company to a4cell
Flow Contract Site Laboratory, LLC Personalized Flow Cytometry Services
LiberaBio - Similar company to a4cell
LiberaBio Addressing "undruggable"​ oncology targets by delivering whole antibodies inside the tumor and metastatic cells.
NAVAN - Similar company to a4cell
NAVAN Transforming Cell Therapy Engineering